BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23755070)

  • 1. Heterogeneity of expression of epithelial-mesenchymal transition markers in melanocytes and melanoma cell lines.
    Kim JE; Leung E; Baguley BC; Finlay GJ
    Front Genet; 2013; 4():97. PubMed ID: 23755070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
    Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
    PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slug expression during melanoma progression.
    Shirley SH; Greene VR; Duncan LM; Torres Cabala CA; Grimm EA; Kusewitt DF
    Am J Pathol; 2012 Jun; 180(6):2479-89. PubMed ID: 22503751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.
    Vachtenheim J; Novotná H
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1075-82. PubMed ID: 10644012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPARC represses E-cadherin and induces mesenchymal transition during melanoma development.
    Robert G; Gaggioli C; Bailet O; Chavey C; Abbe P; Aberdam E; Sabatié E; Cano A; Garcia de Herreros A; Ballotti R; Tartare-Deckert S
    Cancer Res; 2006 Aug; 66(15):7516-23. PubMed ID: 16885349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cadherin switch from E- to N-cadherin in melanoma progression is regulated by the PI3K/PTEN pathway through Twist and Snail.
    Hao L; Ha JR; Kuzel P; Garcia E; Persad S
    Br J Dermatol; 2012 Jun; 166(6):1184-97. PubMed ID: 22332917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
    Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation States of Phenotypic Transition of Melanoma Cells Are Revealed by 3D Cell Cultures.
    Fontana F; Sommariva M; Anselmi M; Bianchi F; Limonta P; Gagliano N
    Cells; 2024 Jan; 13(2):. PubMed ID: 38247872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slug and E-Cadherin: Stealth Accomplices?
    Sterneck E; Poria DK; Balamurugan K
    Front Mol Biosci; 2020; 7():138. PubMed ID: 32760736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of MITF Leads to Transformation in MC1R-Defective Melanocytes.
    Lavelle TJ; Alver TN; Heintz KM; Wernhoff P; Nygaard V; Nakken S; Øy GF; Bøe SL; Urbanucci A; Hovig E
    Cancers (Basel); 2020 Jun; 12(7):. PubMed ID: 32605315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of the epithelial mesenchymal transition factors Snail, Slug, Twist, TGF-β, and E-cadherin in ameloblastoma.
    Kurioka K; Wato M; Iseki T; Tanaka A; Morita S
    Med Mol Morphol; 2017 Jun; 50(2):68-75. PubMed ID: 27995335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF and epithelial-mesenchymal transition in primary cutaneous melanoma: a role for Snail and E-cadherin?
    Mitchell B; Leone DA; Feller JK; Yang S; Mahalingam M
    Hum Pathol; 2016 Jun; 52():19-27. PubMed ID: 26980024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma.
    Caramel J; Papadogeorgakis E; Hill L; Browne GJ; Richard G; Wierinckx A; Saldanha G; Osborne J; Hutchinson P; Tse G; Lachuer J; Puisieux A; Pringle JH; Ansieau S; Tulchinsky E
    Cancer Cell; 2013 Oct; 24(4):466-80. PubMed ID: 24075834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The correlation of TRPM1 (Melastatin) mRNA expression with microphthalmia-associated transcription factor (MITF) and other melanogenesis-related proteins in normal and pathological skin, hair follicles and melanocytic nevi.
    Lu S; Slominski A; Yang SE; Sheehan C; Ross J; Carlson JA
    J Cutan Pathol; 2010 Apr; 37 Suppl 1(Suppl 1):26-40. PubMed ID: 20482673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Theoretical Model of the Wnt Signaling Pathway in the Epithelial Mesenchymal Transition.
    Gasior K; Hauck M; Wilson A; Bhattacharya S
    Theor Biol Med Model; 2017 Oct; 14(1):19. PubMed ID: 28992816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZEB and Snail expression indicates epithelial-mesenchymal transition in canine melanoma.
    Veloso ES; Gonçalves INN; Silveira TL; Espirito Santo JT; Figueiredo LV; Varaschin MS; Cassali GD; Del Puerto HL; Ferreira E
    Res Vet Sci; 2020 Aug; 131():7-14. PubMed ID: 32278962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activation of ZEB1 by Slug leads to cooperative regulation of the epithelial-mesenchymal transition-like phenotype in melanoma.
    Wels C; Joshi S; Koefinger P; Bergler H; Schaider H
    J Invest Dermatol; 2011 Sep; 131(9):1877-85. PubMed ID: 21593765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-to-mesenchymal transition-related transcription factors are up-regulated in ependymomas and correlate with a poor prognosis.
    Malgulwar PB; Nambirajan A; Pathak P; Rajeshwari M; Suri V; Sarkar C; Singh M; Sharma MC
    Hum Pathol; 2018 Dec; 82():149-157. PubMed ID: 30067950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease.
    Travnickova J; Wojciechowska S; Khamseh A; Gautier P; Brown DV; Lefevre T; Brombin A; Ewing A; Capper A; Spitzer M; Dilshat R; Semple CA; Mathers ME; Lister JA; Steingrimsson E; Voet T; Ponting CP; Patton EE
    Cancer Res; 2019 Nov; 79(22):5769-5784. PubMed ID: 31582381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
    Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
    PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.